国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Covid-19 and Vaccines Developed in India

Sonali Das

Coronavirus represents Corona Virus Disease-2019 is a viral infection achieved by serious intense respiratory disorder Covid (SARS-CoV-2) announced as pandemic by World Health Organization (WHO) on 11 March 2020. Coronaviruses are the colossal gathering of infections comes from Coronaviridae, Arteriviridae, and Roniviridae families. The Disease was first recognized in Wuhan, Hubei, China, in December 2019. Most normal side effects are fever, sleepiness, dry hack, sore throat, body torment, the runs, conjunctivitis, cerebral pain, loss of taste and smell, skin rashes, shortness of breath. The COVID-19 taints individuals of any age however two gatherings of individuals are at higher danger. These are old age (individuals over 60 years of age) and individuals with serious ailment, for example, Hypertension, Cardiovascular illness, Diabetes and Cancer. Other than this high risk may happen in pregnant ladies and HIV patients.